Hydroxyurea and Glucocorticoids in Lymphoblasts
Author Information
Author(s): F. Maehira, R.M. Gledhill, A.J. Edwards, M.R. Norman
Primary Institution: King's College School of Medicine & Dentistry
Hypothesis
Hydroxyurea synchronizes CEM-C7 lymphoblasts in S-phase, affecting their sensitivity to glucocorticoids.
Conclusion
Hydroxyurea does not significantly alter the sensitivity of CEM-C7 lymphoblasts to glucocorticoids.
Supporting Evidence
- Hydroxyurea was tested for its ability to synchronize cells in S-phase.
- Prednisolone was used to assess its interaction with hydroxyurea.
- Flow microfluorimetry confirmed that hydroxyurea blocked CEM-C7 cells in S-phase.
Takeaway
This study looked at how a drug called hydroxyurea affects cancer cells when combined with another drug, but it found that hydroxyurea doesn't change how sensitive the cells are to the other drug.
Methodology
CEM-C7 cells were treated with hydroxyurea and prednisolone, and their DNA content was measured using flow microfluorimetry.
Limitations
The study did not find significant interactions between hydroxyurea and prednisolone, which may limit its applicability to other drug combinations.
Want to read the original?
Access the complete publication on the publisher's website